Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Research article

Association between tea consumption and cognitive impairment in middle-aged and older adults

Authors: Jia Zhang, Anxin Wang, Xiaoli Zhang, Shuohua Chen, Shouling Wu, Xingquan Zhao, Qian Zhang

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Biologic studies have suggested that tea may have neuroprotective activity. However, tea’s protective effect on cognitive function is controversial in human epidemiological studies, and no data, including the middle-aged, are available. The objective of this study was to investigate the association of habit, frequency, and types of tea consumption with incident cognitive impairment in middle-aged and older adults.

Methods

Data from the Asymptomatic Polyvascular Abnormalities in Community study were used (aged over 40y). We gathered information on tea consumption, including habit, frequency, and types, via a standardized questionnaire and assessed cognitive function by Mini-Mental State Examination (MMSE) and/or Montreal Cognitive Assessment (MoCA). Three thousand eight hundred sixty-eight and 806 participants were selected in MMSE and MoCA subgroups. Multivariate logistic regression models were utilized to examine associations between tea consumption and cognitive impairment in middle-aged and older participants.

Results

In MMSE analyses, after adjustment for potential confounding factors, habitual (odds ratio (OR) 0.47, [95% confidence interval (CI) 0.33–0.68], p < 0.001) and high frequency (p trend < 0.001) of tea intake were associated with a lower risk of cognitive impairment. The risk of cognitive impairment was lower in green tea consumption (OR 0.36, [95% CI 0.22–0.61], p < 0.001) than other types (OR 0.59, [95% CI 0.38–0.91], p = 0.017). In MoCA analyses, we got similar results.

Conclusions

Habitual tea consumption, especially high-frequency and green tea consumption, was significantly associated with a lower prevalence of cognitive impairment in middle-aged and older individuals.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kakutani S, Watanabe H, Murayama N. Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients. 2019;11(5):1165.CrossRefPubMedCentral Kakutani S, Watanabe H, Murayama N. Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients. 2019;11(5):1165.CrossRefPubMedCentral
2.
go back to reference Ritchie K, Lovestone S. The dementias. Lancet (London, England). 2002;360(9347):1759–66.CrossRef Ritchie K, Lovestone S. The dementias. Lancet (London, England). 2002;360(9347):1759–66.CrossRef
3.
go back to reference Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H. Future directions in Alzheimer's disease from risk factors to prevention. Biochem Pharmacol. 2014;88(4):661–70.CrossRefPubMed Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H. Future directions in Alzheimer's disease from risk factors to prevention. Biochem Pharmacol. 2014;88(4):661–70.CrossRefPubMed
4.
go back to reference Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461–8.CrossRefPubMedPubMedCentral Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461–8.CrossRefPubMedPubMedCentral
5.
go back to reference Ferreira D, Molina Y, Machado A, Westman E, Wahlund LO, Nieto A, et al. Cognitive decline is mediated by gray matter changes during middle age. Neurobiol Aging. 2014;35(5):1086–94.CrossRefPubMed Ferreira D, Molina Y, Machado A, Westman E, Wahlund LO, Nieto A, et al. Cognitive decline is mediated by gray matter changes during middle age. Neurobiol Aging. 2014;35(5):1086–94.CrossRefPubMed
6.
go back to reference Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y. Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules (Basel, Switzerland). 2018;23(6):1297.CrossRef Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y. Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules (Basel, Switzerland). 2018;23(6):1297.CrossRef
7.
go back to reference Cheng TO. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol. 2006;108(3):301–8.CrossRefPubMed Cheng TO. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol. 2006;108(3):301–8.CrossRefPubMed
8.
go back to reference Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. Jama. 2006;296(10):1255–65.CrossRefPubMed Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. Jama. 2006;296(10):1255–65.CrossRefPubMed
9.
go back to reference Sumpio BE, Cordova AC, Berke-Schlessel DW, Qin F, Chen QH. Green tea, the “Asian paradox,” and cardiovascular disease. J Am Coll Surg. 2006;202(5):813–25.CrossRefPubMed Sumpio BE, Cordova AC, Berke-Schlessel DW, Qin F, Chen QH. Green tea, the “Asian paradox,” and cardiovascular disease. J Am Coll Surg. 2006;202(5):813–25.CrossRefPubMed
10.
go back to reference Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med. 2004;37(3):304–17.CrossRefPubMed Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med. 2004;37(3):304–17.CrossRefPubMed
11.
go back to reference Chen SQ, Wang ZS, Ma YX, Zhang W, Lu JL, Liang YR, et al. Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases. Molecules (Basel, Switzerland). 2018;23(3):512.CrossRef Chen SQ, Wang ZS, Ma YX, Zhang W, Lu JL, Liang YR, et al. Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases. Molecules (Basel, Switzerland). 2018;23(3):512.CrossRef
12.
go back to reference Tomata Y, Sugiyama K, Kaiho Y, Honkura K, Watanabe T, Zhang S, et al. Green tea consumption and the risk of incident dementia in elderly Japanese: the Ohsaki cohort 2006 study. Am J Geriatr Psychiatry. 2016;24(10):881–9.CrossRefPubMed Tomata Y, Sugiyama K, Kaiho Y, Honkura K, Watanabe T, Zhang S, et al. Green tea consumption and the risk of incident dementia in elderly Japanese: the Ohsaki cohort 2006 study. Am J Geriatr Psychiatry. 2016;24(10):881–9.CrossRefPubMed
13.
go back to reference Ng TP, Feng L, Niti M, Kua EH, Yap KB. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr. 2008;88(1):224–31.CrossRefPubMed Ng TP, Feng L, Niti M, Kua EH, Yap KB. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr. 2008;88(1):224–31.CrossRefPubMed
14.
go back to reference Fischer K, Melo van Lent D, Wolfsgruber S, Weinhold L, Kleineidam L, Bickel H, et al. Prospective associations between single foods, alzheimer’s dementia and memory decline in the elderly. Nutrients. 2018;10(7):852.CrossRefPubMedCentral Fischer K, Melo van Lent D, Wolfsgruber S, Weinhold L, Kleineidam L, Bickel H, et al. Prospective associations between single foods, alzheimer’s dementia and memory decline in the elderly. Nutrients. 2018;10(7):852.CrossRefPubMedCentral
15.
go back to reference Wang G, Tang HD, Zhuang JP, Xu XH, Liu LH, Li B, et al. Risk factors for cognitive decline in elderly people: findings from the two-year follow-up study in a Shanghai urban community. J Alzheimer’s Dis. 2014;39(4):891–7.CrossRef Wang G, Tang HD, Zhuang JP, Xu XH, Liu LH, Li B, et al. Risk factors for cognitive decline in elderly people: findings from the two-year follow-up study in a Shanghai urban community. J Alzheimer’s Dis. 2014;39(4):891–7.CrossRef
16.
go back to reference Ma C, Gurol ME, Huang Z, Lichtenstein AH, Wang X, Wang Y, et al. Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study. Neurology. 2019;93(5):e445–e57.CrossRefPubMedPubMedCentral Ma C, Gurol ME, Huang Z, Lichtenstein AH, Wang X, Wang Y, et al. Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study. Neurology. 2019;93(5):e445–e57.CrossRefPubMedPubMedCentral
17.
go back to reference Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke. 2013;44(9):2451–6.CrossRefPubMed Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke. 2013;44(9):2451–6.CrossRefPubMed
18.
go back to reference Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Relationship between the Montreal cognitive assessment and mini-mental state examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015;15:107.CrossRefPubMedPubMedCentral Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Relationship between the Montreal cognitive assessment and mini-mental state examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015;15:107.CrossRefPubMedPubMedCentral
19.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed
20.
go back to reference Brown DS, Bernstein IH, McClintock SM, Munro Cullum C, Dewey RB Jr, Husain M, et al. Use of the Montreal cognitive assessment and Alzheimer’s Disease-8 as cognitive screening measures in Parkinson’s disease. Int J Geriat Psychiatry. 2016;31(3):264–72.CrossRef Brown DS, Bernstein IH, McClintock SM, Munro Cullum C, Dewey RB Jr, Husain M, et al. Use of the Montreal cognitive assessment and Alzheimer’s Disease-8 as cognitive screening measures in Parkinson’s disease. Int J Geriat Psychiatry. 2016;31(3):264–72.CrossRef
21.
go back to reference Ozer S, Young J, Champ C, Burke M. A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2016;31(11):1139–50.CrossRefPubMed Ozer S, Young J, Champ C, Burke M. A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2016;31(11):1139–50.CrossRefPubMed
22.
go back to reference Yifeng D, Peiyuan L, Yong J, Liyong W, Lu S. Guidelines for dementia and cognitive impairment in China 2018: the diagnosis and treatment of mild cognitive impairment. Natl Med J China. 2018;98(17):1294–301. Yifeng D, Peiyuan L, Yong J, Liyong W, Lu S. Guidelines for dementia and cognitive impairment in China 2018: the diagnosis and treatment of mild cognitive impairment. Natl Med J China. 2018;98(17):1294–301.
23.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed
24.
go back to reference Salvadori E, Pasi M, Poggesi A, Chiti G, Inzitari D, Pantoni L. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol. 2013;260(9):2220–7.CrossRefPubMed Salvadori E, Pasi M, Poggesi A, Chiti G, Inzitari D, Pantoni L. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol. 2013;260(9):2220–7.CrossRefPubMed
25.
go back to reference Wellens NI, Flamaing J, Tournoy J, Hanon T, Moons P, Verbeke G, et al. Convergent validity of the cognitive performance scale of the interRAI acute care and the mini-mental state examination. Am J Geriatr Psychiatry. 2013;21(7):636–45.CrossRefPubMed Wellens NI, Flamaing J, Tournoy J, Hanon T, Moons P, Verbeke G, et al. Convergent validity of the cognitive performance scale of the interRAI acute care and the mini-mental state examination. Am J Geriatr Psychiatry. 2013;21(7):636–45.CrossRefPubMed
26.
go back to reference Popovic IM, Seric V, Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci. 2007;257(1–2):185–93.CrossRefPubMed Popovic IM, Seric V, Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci. 2007;257(1–2):185–93.CrossRefPubMed
27.
go back to reference Huang S, Li J, Wu Y, Ranjbar S, Xing A, Zhao H, et al. Tea consumption and longitudinal change in high-density lipoprotein cholesterol concentration in chinese adults. J Am Heart Assoc. 2018;7(13):e008814.CrossRefPubMedPubMedCentral Huang S, Li J, Wu Y, Ranjbar S, Xing A, Zhao H, et al. Tea consumption and longitudinal change in high-density lipoprotein cholesterol concentration in chinese adults. J Am Heart Assoc. 2018;7(13):e008814.CrossRefPubMedPubMedCentral
28.
go back to reference Wang L, Cui L, Wang Y, Vaidya A, Chen S, Zhang C, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int J Epidemiol. 2015;44(2):689–99.CrossRefPubMedPubMedCentral Wang L, Cui L, Wang Y, Vaidya A, Chen S, Zhang C, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int J Epidemiol. 2015;44(2):689–99.CrossRefPubMedPubMedCentral
29.
go back to reference Ortiz-Lopez L, Marquez-Valadez B, Gomez-Sanchez A, Silva-Lucero MD, Torres-Perez M, Tellez-Ballesteros RI, et al. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro. Neuroscience. 2016;322:208–20.CrossRefPubMed Ortiz-Lopez L, Marquez-Valadez B, Gomez-Sanchez A, Silva-Lucero MD, Torres-Perez M, Tellez-Ballesteros RI, et al. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro. Neuroscience. 2016;322:208–20.CrossRefPubMed
30.
go back to reference Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, et al. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002;277(47):45518–28.CrossRefPubMed Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, et al. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002;277(47):45518–28.CrossRefPubMed
31.
go back to reference Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem. 2004;15(9):506–16.CrossRefPubMed Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem. 2004;15(9):506–16.CrossRefPubMed
33.
go back to reference Lin YS, Tsai YJ, Tsay JS, Lin JK. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem. 2003;51(7):1864–73.CrossRefPubMed Lin YS, Tsai YJ, Tsay JS, Lin JK. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem. 2003;51(7):1864–73.CrossRefPubMed
34.
go back to reference Walhovd KB, Fjell AM, Espeseth T. Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view. Scand J Psychol. 2014;55(3):244–54.CrossRefPubMed Walhovd KB, Fjell AM, Espeseth T. Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view. Scand J Psychol. 2014;55(3):244–54.CrossRefPubMed
35.
go back to reference Ferreira D, Correia R, Nieto A, Machado A, Molina Y, Barroso J. Cognitive decline before the age of 50 can be detected with sensitive cognitive measures. Psicothema. 2015;27(3):216–22.PubMed Ferreira D, Correia R, Nieto A, Machado A, Molina Y, Barroso J. Cognitive decline before the age of 50 can be detected with sensitive cognitive measures. Psicothema. 2015;27(3):216–22.PubMed
36.
go back to reference Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimer’s Dis. 2009;16(1):85–91.CrossRef Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimer’s Dis. 2009;16(1):85–91.CrossRef
37.
go back to reference Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, et al. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging. 2015;19(3):313–28.CrossRefPubMed Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, et al. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging. 2015;19(3):313–28.CrossRefPubMed
38.
go back to reference Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94.CrossRefPubMed Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94.CrossRefPubMed
Metadata
Title
Association between tea consumption and cognitive impairment in middle-aged and older adults
Authors
Jia Zhang
Anxin Wang
Xiaoli Zhang
Shuohua Chen
Shouling Wu
Xingquan Zhao
Qian Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01848-6

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue